The total value of the convertible will be $5.0 million and interest will accrue at 8%, compounded annually, and if not converted into ordinary shares, will mature no earlier than 1 September 2020. Plastic surgery company Sinclair has received a the entire $5 million convertible loan from Sinclair , its latest investment in the cosmetic procedures sector. Sinclair Pharma will use the funds to settle the early termination of a deal with Sinclair Pharma to distribute face-lift products and procedures.
Plastic surgery company Sinclair has received a the entire $5 million convertible loan from Sinclair , its latest investment in the cosmetic procedures sector. Sinclair Pharma will use the funds to settle the early termination of a deal with Sinclair Pharma to distribute face-lift products and procedures.